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ABSTRACT
Objectives Patients with allergic rhinitis receive their 
information about administering intranasal corticosteroid 
sprays (INCS) from healthcare workers. Since the majority 
of patients does not administer these sprays correctly, we 
investigated whether healthcare workers know how to 
administer INCS.
Settings We studied participants at their working place: 
pharmacy, outpatient clinic or general practitioner centre 
for emergencies.
Participants Pharmacist assistants, general practitioners, 
paediatricians and ear nose throat doctors.
Design Observational study. All the participants 
demonstrated the administration technique with a spray 
device filled with water.
Primary outcome Number of steps of administration of 
INCS based on the established INCS protocol.
Secondary outcome Number of five steps are labelled 
essential to obtain optimal distribution of the medication.
Results Among the 75 participants, none performed all 
the steps correctly. The median of correctly performed 
steps in the protocol was 14 out of 29. A significantly 
better result was found among the pharmacist assistants. 
The essential steps were performed by 27 out of the 75 
participants (36%).
Conclusion The majority of healthcare workers does not 
know how to administer INCS correctly. Patients could, 
therefore, receive incorrect and non- uniform instructions. 
The education of healthcare workers on how to administer 
INCS correctly may be an option for improvement.
INTRODUCTION
Allergic rhinitis is a common chronic disease, 
with a prevalence ranging from 10% to 40% 
worldwide.1 The disease mostly affects people 
between 5 and 45 years old, with a peak inci-
dence between 19 and 24 years old.2 In addi-
tion to allergen avoidance, the management 
of allergic rhinitis consists of either antihista-
mines, intranasal corticosteroids or a combi-
nation of both.3 4 When persistent symptoms 
occur, intranasal corticosteroid sprays (INCS) 
are the treatment of choice.5 6
Studies suggest that the administration 
technique for INCS is associated with effi-
cacy, adverse events and compliance.4 7 
For example, it was found that the optimal 
administration technique of INCS is spraying 
with a contralateral spray technique, 
pointing the nozzle away from the septum, 
because spraying towards the septum causes 
more nosebleeds than the recommended 
approach.7–9 Furthermore, the head should 
be kept in a neutral position, and it is 
important to breathe in calmly while spraying. 
This technique provides the best distribution 
of the medication.10–12
In a recent study, we observed the method 
of administration among patients and found 
that most (94%) did not take their INCS as 
described in the patient information leaflets 
(PILs).13 Moreover, the available PILs are 
currently incomplete and non- uniform.14 
Since patients do not only learn from PILs 
but can also be instructed by healthcare 
workers, we wanted to know whether they 
could demonstrate the administration of 
INCS correctly. As far as we know, this factor 
has never previously been studied. Therefore, 
we investigated the knowledge of healthcare 
workers regarding administering INCS.
MATERIALS AND METHODS
Participants and setting
We performed an observational study in 
the northern part of the Netherlands. The 
healthcare workers observed included phar-
macist assistants, general practitioners (GPs), 
Strengths and limitations of this study
 ► This is the first study to observe healthcare workers 
administering intranasal corticosteroid sprays.
 ► We conducted this study in a small research group, 
consisting of 75 healthcare workers.
 ► The administration technique was scored in a sim-
ple and robust way by the same investigator.
 ► We used a protocol for correct administration based 
on the literature and patient information leaflets, 
















pen: first published as 10.1136/bm





2 de Boer M, et al. BMJ Open 2020;10:e037660. doi:10.1136/bmjopen-2020-037660
Open access 
paediatricians and ear nose throat (ENT) physicians. 
Healthcare workers were excluded if they had been prac-
tising their profession for less than a year. Paediatricians 
and ENT physicians from eight hospitals were approached 
via email. We approached pharmacist assistants from six 
pharmacies. GPs were approached while working at the 
GP centre for emergencies based at the Medical Centre 
Leeuwarden.
Study design
When eligible healthcare workers agreed to participate, 
a face- to- face interview was conducted. All the partici-
pants were aware of the aim of the study. To prevent inter- 
observer variation, all interviews and observations were 
performed by the same researcher (MdB).
During the interviews, the healthcare workers answered 
a questionnaire containing questions about their expe-
riences prescribing INCS and about how they provide 
patients with information. Then, the healthcare workers 
were asked to demonstrate the administration technique 
with a spray device filled with water. The stages assessed 
were preparation, administration and cleaning of the 
INCS (box 1). Assessment of the administration tech-
nique was based on the established Dutch INCS protocol. 
During administration, this protocol was used as a scoring 
sheet, consisting of 29 steps. One point was given each 
time the participant performed a step correctly. In the 
INCS protocol, five steps are labelled as essential.14 These 
steps are considered as essential because they most influ-
ence the distribution and efficacy of the medication. The 
essential steps include shaking the bottle, blowing or 
rinsing the nose, directing the nebuliser away from the 
nasal septum, breathing in while simultaneously squirting 
a spray of mist and exhaling through the mouth.
Statistical analysis
In the statistical analysis, descriptive statistics were used to 
answer the question of whether healthcare workers know 
how to administer INCS. For the comparison of outcomes 
between populations, a Kruskal- Wallis test was used. Post 
hoc analysis was performed using a Mann- Whitney U 
test. The regional medical ethics committee approved 
the study protocol. All the participants provided written 
consent.
Patient and public involvement
Patients or the public were not involved in the design, 
or conduct, or reporting or dissemination plans of our 
research.
RESULTS
In the period between 11 June 2019 and 18 December 
2019, 10 ENT departments, seven paediatrician depart-
ments and eight pharmacies were asked to participate in 
this study. GPs were approached at the GP’s emergency 
centre and asked to participate on the spot. Seventy- five 
healthcare workers participated in our study (table 1), 
none of them performed all the steps correctly. The 
median of correctly performed steps in the protocol was 
14 out of 29, with a range between 9 and 24 and an IQR 
of 3.5. For preparing the spray, the median was six out of 
seven steps. The median for administering the spray was 
8 out of 10 steps and the median for cleaning the spray 
was 1 out of 10 steps. The points for attention, which are 
taking the spray to the pharmacy when it does not work 
and checking the expiry date, were not performed by 
most participants (figure 1). When analysing the differ-
ences in total score between the healthcare workers, a 
significantly higher result was found among pharmacist 
assistants compared with the other groups (table 2).
Box 1 Assessed steps per stage of the intranasal 
corticosteroid sprays protocol
Preparation
1. Discuss the purpose and action of the medication.
2. Take off the dust cap.
3. Firmly shake the bottle.*
4. Place forefinger and middle finger on both sides of the nozzle and 
place thumb underneath the bottle.
5. Point the nozzle upwards and away from yourself.
6. Squirt a few sprays into the air until you see a cloud of mist.
7. Blow the nose or rinse the nose with saline if the nose is clogged.*
Administration
8. Place forefinger and middle finger on both sides of the nozzle and 
place thumb underneath the bottle.
9. A. Keep the head upright and place the nozzle in the nose.
B.Use the right hand for spraying in the left nostril and the left 
hand for spraying in the right nostril.
10. Point the end of the nozzle slightly outwards, away from the centre 
ridge of the nose.*
11. Close the other nostril with your opposite hand.
12. Squirt a spray of mist in the nose while breathing in.*
13. Breathe out through the mouth.*
14. Repeat steps 8 through 13 for the other nostril.
15. If two sprays per nostril are prescribed, repeat steps 8 through 14 
for both nostrils.
16. Replace the dust cap.
Cleaning
17. Wipe the nozzle with a tissue or handkerchief after every use.
18. Extensively wash the nozzle once a week:
19. Take off the dust cap and nozzle.
20. Rinse the dust cap and nozzle with warm water.
21. Shake off water.
22. Air- dry the dust cap and nozzle.
23. Replace the nozzle.
24. Firmly shake the bottle.
25. Squirt a few sprays into the air until you see a cloud of mist.
26. Replace the dust cap.
Points for attention
27. If the nozzle does not spray properly, perform the cleaning steps. If 
this does not work, take the spray to the pharmacy. Never puncture 
the opening.
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Twenty- seven out of 75 participants (36%) performed 
all the essential steps. Of the essential steps, nose blowing 
was performed least frequently, being carried out 46 out 
of 75 times (61%). Inhaling while squirting a spray of mist 
into the open nostril was performed most often: 69 out 
of 75 times (92%). Shaking the bottle was done 61 times 
(81%). The nozzle was directed outwards 66 times (88%). 
Exhaling through the mouth was done by 57 participants 
(76%) (table 3).
Sixteen participants (21%) performed all the prepara-
tion steps. The least performed steps during preparation 
were activating the nozzle by spraying in the air (59%) 
and blowing or rinsing the nose (61%). Two participants 
(3%) performed all the administration steps. Squirting 
the spray while breathing in (92%) and pointing the 
nozzle outwards (88%) were performed by most partic-
ipants. The most frequent errors in administration were, 
in order, keeping the other nostril closed, spraying cross-
wise and keeping the head upright. These steps were 
performed 33 times (44%), 43 times (47%) and 49 times 
(65%), respectively. One participant (1%) performed all 
the cleaning steps, including cleaning the nozzle with a 
tissue and extensively cleaning the nozzle with water once 
a week and allowing it to air- dry. Approximately, half the 
participants (38; 51%) cleaned the spray with a tissue 
after every use (table 3).
DISCUSSION
In this study, we found that most healthcare workers 
involved in the care for patients with allergic rhinitis did 
not know and could not demonstrate how to administer 
INCS correctly. None of the healthcare workers performed 
all the steps of the checklist correctly. The median of the 
75 participants was 14 out of 29 well- executed steps. The 
five essential steps were correctly performed by 27 out 
of 75 participants (36%). We found that the pharmacist 
assistants administered the INCS significantly better than 
the other healthcare workers, suggesting that pharmacist 
assistants are most suitable for providing information 
about INCS.
To the best of our knowledge, the role of healthcare 
workers in informing patients about the correct admin-
istration of INCS has never previously been studied. One 
recent study found that face- to- face instruction, consisting 
of both verbal information and a physical demonstra-
tion, was most effective in teaching the correct tech-
nique for asthma medication.15 This finding may apply 
regarding the correct usage of INCS as well, meaning 
Table 1 Participant characteristics
Variable Overall (n=75)
Healthcare worker, n (%)
  Pharmacist assistant 20 (26)
  General practitioner 20 (26)
  Paediatrician 20 (26)
  ENT physician 15 (20)
Gender, n (%)
  Male 27 (36)
  Female 48 (64)
Age (mean), range (95% CI)
  45.2±11
Years of professional practice, n (%)
  1–5 years 18 (24)
  5–10 years 12 (16)
  10–20 years 22 (29)
  >20 years 23 (31)
Number of INCS prescriptions per week, n (%)
  0 times 20 (27)
  <1 time 19 (25)
  1–4 times 17 (23)
  4–8 times 5 (7)
  >8 times 14 (19)
Number of INCS instructions per week, n (%)
  <1 time 24 (32)
  1–4 times 27 (36)
  4–8 times 9 (12)
  >8 times 15 (20)
Number of checks on INCS inhalations per week, n (%)
  <1 time 62 (83)
  1–4 times 15 (14)
  4–8 times 2 (3)
  >8 times 0 (0)
Use of information material, n (%)
  Yes 19 (25)
  No 56 (75)
ENT, ear nose throat; INCS, intranasal corticosteroid sprays.
Figure 1 Median score checklist per stage, per group of 
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that it is important that healthcare workers have suffi-
cient knowledge. Knowledge about inhaler technique for 
asthma and chronic obstructive pulmonary disease has 
been researched using healthcare workers. These studies 
reveal similar results to ours; that is, inadequate knowl-
edge regarding the use of inhalers.16 17 A recent study 
found only 12% of healthcare workers knew at least three 
essential steps of the correct metered- dose inhaler tech-
nique, and none of the participants performed all the 
steps correctly.18
For the checklist, we used a standardised protocol 
recently published in Dutch healthcare. Although this 
protocol is based on the existing literature, a few instruc-
tion steps are only marginally substantiated by research 
data, and we needed to make a few assumptions about 
the best spray technique (table 4). First, an essential step 
while preparing for administration is blowing or rinsing 
the nose. This step is recommended in the literature, 
although no significantly better distribution of the active 
substance was found.19 Approximately 60% of the partic-
ipants performed this step. Next, it was found that an 
upright position of the head while spraying proved most 
effective.10 20 Bending the head backwards can result in 
the active substance leaking into the pharynx, causing 
irritation and possibly more systemic uptake. When 
bending the head forward, the active substance could 
easily run out again. However, 45% of the ENT doctors 
and 10%–20% of the paediatricians, GPs and pharma-
cist assistants bent their heads forward while breathing 
in the spray. Their reasoning was that the nasal cavity 
runs backwards, causing the spray to be sprayed towards 
the nasal cavity when the head is bent forward. There is 
a study that confirms this theory.12 When administering 
the nasal spray, the nozzle should be directed away from 
the nasal septum to prevent nose bleeding and septum 
perforation. Furthermore, the lateral nasal wall has more 
cilia than the medial wall, so the distribution of the active 
substance is better.7 9 We found that this essential step 
was performed correctly by 88% of the participants. It is 
also advised to use the contralateral hand while spraying, 
because this causes less mechanical irritation, and, thus, 
fewer side effects and better compliance.7 Approxi-
mately half the participants (57%) performed this step. 
However, not all these participants recommended this 
step to their patients, because it is relatively complicated 
to perform. Another essential step is to breathe in slowly 
during administration, because the airflow ensures a 
better contribution of the active substance. A continuous, 
slow flow has the best effect. Breathing hard or sniffing 
can lead to increased turbulence in the nose, which can 
cause the active substance to finish in the pharynx.11 21 
This was the best- performed essential step: 92% of partic-
ipants performed this correctly. Only one participant 
stated that the nasal spray should be completely cleaned 
with water once a week. Since these nasal sprays are used 
chronically and daily in many cases, good hygiene is 
important. However, there is no uniform instruction for 
cleaning the nasal spray in the package leaflets. This lack 
is a possible explanation why the healthcare workers did 
not mention this aspect. Considering that there is little 
substantiated research about the correct administration 
technique, and since the published INCS protocol is not 
widely known, healthcare providers apparently provide 
instructions according to their own insights. Further 
research is necessary to substantiate the most effective 
administration technique for nasal sprays. Currently, it is 
important to implement the presently available instruc-
tions to achieve clarity in the instructions for the adminis-
tration of nasal sprays.
Strengths and limitations
This study has a couple of limitations. First, we did not 
know what outcomes to expect, so we chose to conduct 
this research with a relatively small research group in a 
particular region.22 Further research must determine to 
what extent our results apply to other regions and coun-
tries. Second, we could only include 15 ENT doctors 
despite many attempts and visits to their offices. Reasons 
given were that they were too busy or not interested in 
participating. Nevertheless, we do not think that the inclu-
sion of five more ENT doctors would affect the outcome 
significantly. Third, it is possible that healthcare workers 
only agreed to participate in this study when they felt an 
affinity with the topic. Greater interest might influence 
the knowledge of a correct administration technique. 
Healthcare workers with less affinity would possibly score 
lower. Given the disappointing results of the studied 
population, this only highlights the fact that the health-
care workers’ knowledge about the correct administra-
tion technique must improve. Finally, we studied the 
Table 2 Difference in total score checklist
Healthcare worker N Median Mean Mean rank P value between groups*
Pharmacist assistant 20 16 16.2 54.58† 0.001
General practitioner 20 13.5 13.3 30.98
Paediatrician 20 14 13.8 34.85
ENT physician 15 12 13.1 29.47
Tested using Kruskal- Wallis test (post hoc Mann- Whitney U).
*p<0.05.
†Significant difference compared with general practitioners, paediatricians and ENT physicians.
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knowledge of healthcare workers, not the actual instruc-
tion patients receive from them.
The strengths of this study are as follows: since various 
hospitals, general practices and pharmacies were 
included, the results are a good reflection of the popu-
lation that both prescribes and informs about INCS. All 
our interviews were conducted by the same researcher, 
so no interobserver variation occurred. We used a simple 
scoring system, making the scores less sensitive to errors.
This research only studied healthcare workers’ knowl-
edge of the administration technique. Studying whether 
the knowledge of a healthcare worker ultimately affects 
the correct spray technique, and, thus, the efficacy of 
INCS in patients is recommended.
CONCLUSION
The majority of healthcare workers does not know how 
to administer an INCS correctly. This lack of knowledge 
may prevent them from being able to provide adequate 
instructions to their patients. Clear arrangements should 
be made regarding who provides these instructions and 
what these instructions include. Healthcare workers 
should continually update their knowledge regarding the 
Table 3 Number of well- executed steps protocol
Preparation n (%)
  Discuss the purpose and action of the medication. 75 (100)
  Take off the dust cap. 75 (100)
  Firmly shake the bottle.* 61 (81)
  Place forefinger and middle finger on both sides of the nozzle and place thumb underneath the 
bottle.
58 (77)
  Point the nozzle upwards and away from yourself. 44 (59)
  Squirt a few sprays into the air until you see a cloud of mist. 44 (59)
  Blow the nose or rinse the nose with saline if the nose is clogged.* 46 (61)
Administration n (%)
  Place forefinger and middle finger on both sides of the nozzle and place thumb underneath the 
bottle.
60 (80)
  A. Keep the head upright and place the nozzle in the nose. 49 (65)
  B.Use the right hand for spraying in the left nostril, and the left hand for spraying in the right nostril. 43 (57)
  Point the end of the nozzle slightly outwards, away from the centre ridge of the nose.* 66 (88)
  Close the other nostril with your opposite hand. 33 (44)
  Squirt a spray of mist in the nose while breathing in.* 69 (92)
  Breathe out through the mouth.* 57 (76)
  Repeat steps 8 through 13 for the other nostril. 75 (100)
  If two sprays per nostril are prescribed, repeat steps 11 through 16 for both nostrils. 75 (100)
  Replace the dust cap. 75 (100)
Cleaning n (%)
  Wipe the nozzle with a tissue or handkerchief after every use. 38 (51)
  Extensively wash the nozzle once a week: 1 (1)
  Take off the dust cap and nozzle. 1 (1)
  Rinse the dust cap and nozzle with warm water. 4 (6)
  Shake off water. 1 (1)
  Air- dry the dust cap and nozzle. 1 (1)
  Replace the nozzle. 1 (1)
  Firmly shake the bottle. 1 (1)
  Squirt a few sprays into the air until you see a cloud of mist. 1 (1)
  Replace the dust cap. 1 (1)
Points for attention n (%)
  If the nozzle does not spray properly, perform the cleaning steps. If this does not work, take the 
spray to the pharmacy. Never puncture the opening.
13 (17)
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correct spray technique. The established INCS protocols 
can be used to address this issue.
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Table 4 Scientifically and non- scientifically based steps in the corticosteroid nasal spray protocol
Scientifically based steps Non- scientifically based steps
 ► Blow the nose or rinse the nose with saline if the nose is 
clogged.19
 ► Firmly shake the bottle.
 ► Keep the head upright.10 20  ► Squirt a few sprays into the air until you see a cloud of mist.
 ► Use the right hand for spraying in the left nostril and the left 
hand for spraying in the right nostril.12
 ► Close the other nostril with your opposite hand.
 ► Point the end of the nozzle slightly outwards, away from the 
centre ridge of the nose.
 ► Breathe out through the mouth.
 ► Squirt a spray of mist in the nose while breathing in.  ► Wipe the nozzle with a tissue or handkerchief after every 
use.
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